CardioLogs ECG Analysis Platform vs Cardiomo

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 75/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
CardioLogs ECG Analysis Platform
by Cardiologs Technologies (now part of Philips)
VS
Cardiomo
by Cardiomo, Inc.

AI Verdict

CardioLogs ECG Analysis Platform is primarily a cloud-based AI solution for analyzing ECG data from various devices, focusing on arrhythmia detection for clinicians. Cardiomo, while also using AI for cardiovascular disease detection, centers around a medical-grade wearable device for continuous, remote heart health monitoring and real-time alerts for users and caregivers. While both address cardiology with AI, CardioLogs is a diagnostic aid for professionals, whereas Cardiomo is a remote monitoring solution with a direct-to-consumer or caregiver component.

Choose CardioLogs ECG Analysis Platform if…

Choose Cardiologs ECG Analysis Platform if your healthcare facility requires a robust, AI-powered solution for rapid and accurate analysis of ECG data from a variety of cardiac monitoring devices, including Holters, smartwatches, and ECG patches. This platform is ideal for cardiologists and other qualified healthcare professionals seeking to efficiently detect and diagnose arrhythmias in both adult and pediatric populations (over 18 in the US and Australia) and integrate with existing EHR systems.

View CardioLogs ECG Analysis Platform →

Choose Cardiomo if…

Choose Cardiomo if you need a continuous, remote heart health monitoring solution for patients, particularly those with existing heart conditions or who are elderly, where real-time alerts to users, caregivers, and medical professionals are crucial. This medical-grade wearable patch offers long battery life and monitors multiple vital signs beyond just ECG, including respiration and skin temperature, making it suitable for proactive, long-term cardiovascular disease detection and prevention.

View Cardiomo →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CardioLogs ECG Analysis Platform Cardiomo
Pricing Contact sales for customized quote Contact for pricing
Deployment Cloud-based (SaaS) Cloud-based with wearable device and mobile app
FDA Status 1 AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cardiomo

Cardiomo offers a wearable patch for continuous, real-time monitoring, which is generally more user-friendly for patients than traditional ECG analysis platforms. Its mobile app provides color-coded alerts and reminders, enhancing ease of use for both patients and caregivers.

Clinical Value

CardioLogs ECG Analysis Platform

CardioLogs ECG Analysis Platform has extensive clinical validation, with over 20 peer-reviewed publications and abstracts, and was the first FDA-cleared ECG analysis solution powered by deep learning technology. It has demonstrated superior performance in detecting atrial arrhythmias compared to some consumer wearables.

Pricing & Value

Tie

Both tools require contacting sales for customized quotes, making direct pricing comparison difficult. While Cardiomo previously had public pricing, it is no longer available. Therefore, without transparent pricing, it's challenging to determine which offers better value.

Enterprise Readiness

CardioLogs ECG Analysis Platform

CardioLogs, now a Philips solution, is designed for integration with EHR systems and offers a cloud-based platform for rapid and efficient analysis of ECG data from various cardiac monitoring devices, indicating strong enterprise readiness. Its FDA clearance and ISO/IEC 27001 certification further support its suitability for enterprise-level deployment.

Innovation

CardioLogs ECG Analysis Platform

CardioLogs pioneered the development of medical-grade AI for ECG analysis, being the first FDA-cleared solution using deep learning technology in 2017. It continues to innovate by exploring the use of deep neural networks to develop ECG biomarkers and analyze cardiac data from smartwatches.

Support & Docs

Tie

Neither the provided structured facts nor web searches offered specific details on the breadth or depth of support and documentation for either tool. Therefore, a definitive winner cannot be determined in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CardioLogs ECG Analysis Platform Cardiomo
Company Cardiologs Technologies (now part of Philips) Cardiomo, Inc.
Tagline Reinventing cardiology diagnostics with medical-grade AI and cloud technology. A medical-grade wearable device that monitors vital signs and uses an AI engine to detect cardiovascular diseases and provide life-saving alerts.
Key Feature: AI-Powered Analysis AI-Powered ECG Analysis (Deep Neural Networks), Automated Arrhythmia Detection (e.g., AFib, VT) AI-powered disease detection (arrhythmias, cardiovascular events)
Key Feature: Device Compatibility Multi-Device Compatibility (Holter, smartwatches, ECG patches) Medical-grade wearable patch

Videos

Demos, reviews, and walkthroughs featuring CardioLogs ECG Analysis Platform and Cardiomo.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

CardioLogs ECG Analysis Platform can integrate with EHR systems, and Philips IntelliBridge Enterprise solution can further simplify this integration. This allows for streamlined ECG analysis and reporting within existing clinical workflows. Cardiomo's platform collects vital signs and analyzes data in a HIPAA-compliant cloud, enabling medical professionals to monitor patients in real-time. Modern EHRs connect with remote patient monitoring (RPM) through HL7 FHIR standards, API connections, and middleware that normalizes data from different monitoring devices, allowing automatic capture of vital signs and alerts directly into clinical workflows.
CardioLogs ECG Analysis Platform has reported a sensitivity of 97% and a positive predictive value (PPV) of 91% for detecting Atrial Fibrillation (AF), which is superior to conventional methods. Cardiomo claims 99.63% accuracy in detecting cardiac events and providing early alerts. Wearable cardiac monitors generally demonstrate sensitivity ranging from 84% to 95% and specificity up to 93% for arrhythmia detection.
While specific learning curve data for these exact platforms isn't provided, AI-guided technology in cardiac imaging has been shown to facilitate imaging and shorten training for novice operators. Cardiologs' technology is developed to accelerate diagnostic reporting and streamline clinician workflow, which could suggest a focus on ease of use and a reduced learning curve. Cardiomo is described as user-friendly and practical.
CardioLogs, as a Philips solution, offers support to help healthcare providers diagnose patients more efficiently. Cardiomo aims to reduce the distance between patient and practitioner and provides instant notifications to patients, relatives, and care providers. Generally, support for medical devices can include personalized education and direct technical assistance.
While not explicitly detailed for both tools, a key requirement for HIPAA compliance in cardiology information systems is event logging and user authentication. This allows for the creation of reports detailing each user who accesses a patient's data, which is essential for audit trails. Secure systems generally log and audit all access to data.
CardioLogs is a cloud-based platform, which inherently supports accessibility from various locations. Its vendor-neutrality also allows it to support recordings from different devices, which can be beneficial in multi-site environments. For large cardiology groups, EHR integration that provides bi-directional connectivity and consolidates vendor-neutral device data is crucial for consistent workflows across locations.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring CardioLogs ECG Analysis Platform or Cardiomo

Backers

Who funded each tool's parent company.

Cardiomo

AI Tool Finder
AI-powered search. Results may not be comprehensive.